Mammaglobin immunostaining in the differential diagnosis between cutaneous apocrine carcinoma and cutaneous metastasis from breast carcinoma
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
20301838
Knihovny.cz E-zdroje
- MeSH
- apokrinní žlázy * MeSH
- diferenciální diagnóza MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mammaglobin A MeSH
- nádorové biomarkery analýza MeSH
- nádorové proteiny analýza MeSH
- nádory kůže diagnóza sekundární MeSH
- nádory potních žláz diagnóza sekundární MeSH
- nádory prsu patologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- uteroglobin analýza MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- mammaglobin A MeSH
- nádorové biomarkery MeSH
- nádorové proteiny MeSH
- SCGB2A2 protein, human MeSH Prohlížeč
- uteroglobin MeSH
The differential diagnosis between cutaneous apocrine carcinoma (CAC) and cutaneous metastases from breast carcinoma is commonly difficult. Many times, clinical information is crucial in the final diagnosis, because help that can be obtained from immunohistochemistry is usually limited concerning this subject. We used the antibody mammaglobin in order to study 10 cases of cutaneous metastasis of ductal breast carcinoma, and 2 cases of CAC. One of the CAC cases showed only scattered positive cells, while the other did not show any positivity. Four cases of metastatic breast carcinoma also showed scattered positive cells. In other five metastatic cases, positive cells were abundant, representing up to 60% of the tumoral cells. One case of metastatic breast carcinoma did not show any expression of mammaglobin at all. Although, more cases of CAC should probably be studied in the future before any categorical conclusion can be obtained, our results seem to indicate that a pattern of immunostaining with expression of mammaglobin in many cells would favor a metastatic origin of the tumor.